Literature DB >> 837532

L-p-Bromotetramisole, a new reagent for use in measuring placental or intestinal isoenzymes of alkaline phosphatase in human serum.

H Van Belle, M E De Broe, R J Wieme.   

Abstract

L-p-Bromotetramisole is proposed as a new reagent for use in determining intestinal and (or) placental isoenzymes of alkaline phosphatase in human serum. Its main advantage over L-phenylalanine is its high discriminating potency at very low concentrations. For highest accuracy, the samples may even be "titrated" with the inhibitor. Analytical recoveries of intestinal and placental isoenzymes in serum are complete, and results correlate well with those by other methods. At the appropriate concentrations, L-p-bromotetramisole gives nearly identical results on a variety of sera, irrespective of the buffer used. Within-day CV's were 6.1 and 2.1 for 20% and 60% of the resistant isoenzyme activity, respectively. The day-to-day CV was 3.45 for a sample containing 53.3% of the resistant isoenzyme (n=15). The well-known increase in placental isoenzyme activity with time of gestation could be confirmed on 612 sera from pregnant women. The activities of the intestinal isoenzyme in sera from healty blood donors (n = 126) and hospitalized patients (n = 135) agree with previous findings obtained by the other techniques.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837532

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Dissociation of leukocyte alkaline phosphatase from the bactericidal activity of neutrophils.

Authors:  L R DeChatelet; P S Shirley; C E McCall; D A Bass
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

2.  Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis.

Authors:  A Boué; F Muller; C Nezelof; J F Oury; F Duchatel; Y Dumez; M C Aubry; J Boué
Journal:  Hum Genet       Date:  1986-11       Impact factor: 4.132

3.  Alkaline Phosphatase Activity Is a Key Determinant of Vascular Responsiveness to Norepinephrine.

Authors:  Edwin K Jackson; Dongmei Cheng; Vladimir B Ritov; Zaichuan Mi
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

4.  Further characterization of phosphatase activities using non-specific substrates.

Authors:  M Borgers; F Thoné
Journal:  Histochem J       Date:  1976-05

5.  Measurement of alkaline phosphatase of intestinal origin in plasma by p-bromotetramisole inhibition.

Authors:  T Kuwana; S B Rosalki
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

6.  Gly429 is the major determinant of uncompetitive inhibition of human germ cell alkaline phosphatase by L-leucine.

Authors:  C Hummer; J L Millán
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

7.  Establishment and characterization of cell lines from the Walker carcinoma 256 able to grow in suspension culture and deficient in thymidine kinase.

Authors:  F Arvelo; A Yabrudi; M E Delgado; N González-Cadavid
Journal:  In Vitro       Date:  1984-07

8.  Heat-stable alkaline phosphatase as a marker for human and monkey type-I pneumocytes.

Authors:  E J Nouwen; N Buyssens; M E De Broe
Journal:  Cell Tissue Res       Date:  1990-05       Impact factor: 5.249

9.  Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.

Authors:  E J Nouwen; P G Hendrix; S Dauwe; M W Eerdekens; M E De Broe
Journal:  Am J Pathol       Date:  1987-02       Impact factor: 4.307

10.  Plasma intestinal alkaline phosphatase and intermediate molecular mass gamma glutamyltransferase activities in the differential diagnosis of jaundice.

Authors:  D Collins; M F Goold; S B Rosalki; P D Mayne; A Y Foo
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.